Eszopiclone is classified as a nonbenzodiazepine hypnotic agent that selectively binds to the gaba a receptor. This binding enhances the activity of the inhibitory neurotransmitter gaba, increasing chloride influx into neuronal cells. The resulting hyperpolarization produces sedative effects that facilitate sleep onset and maintenance. Eszopiclone is prescribed for the short term treatment of insomnia characterized by difficulty staying asleep. After oral administration the drug is metabolized in the liver and eliminated mainly through renal pathways. The mechanism of action involves prolonged opening of chloride channels which leads to neuronal inhibition and the induction of sleep.

Eszopiclone is a nonbenzodiazepine hypnotic medication used to promote sleep in adults with insomnia. Its therapeutic role is to reduce the time it takes to fall asleep and to maintain sleep throughout the night. The drug acts as a selective agonist at the gaba-a receptor, enhancing the natural inhibitory effects of gamma-aminobutyric acid in the brain. By binding to specific subunits of the receptor, Eszopiclone increases the opening duration of chloride channels, leading to neuronal hyperpolarization. This modulation reduces cortical activity and produces a calming effect that facilitates the onset and continuity of sleep. The overall pharmacological activity of Eszopiclone therefore translates into improved sleep latency and efficiency without significant sedation during waking hours.

Insomnia medication Eszopiclone can cause a metallic taste in the mouth after dosing. Some users report feeling drowsy or sedated even after waking up from sleep. Dizziness and lightheadedness are reported side effects that may affect balance. Dry mouth and difficulty swallowing have been observed in clinical studies. Behavioral changes such as sleepwalking, sleep-driving, or sleep-eating are documented risks. Memory problems including trouble recalling recent events may occur. Headache and gastrointestinal discomfort are common complaints among patients. Unusual changes in mood such as increased anxiety or depression can be associated with use.

Eszopiclone can cause a lingering feeling of drowsiness that may affect daily activities. Some people experience a bitter or metallic taste shortly after taking the medication. Dizziness or light-headedness is reported, especially when standing up quickly. Headaches and muscle aches are common adverse reactions. Memory problems such as difficulty recalling recent events have been documented. Unusual dreams or vivid nightmares may occur during use. Rarely, users report feelings of aggression or agitation. The drug can depress respiratory function in individuals with pre-existing lung conditions.